These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22107817)

  • 21. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.
    Morsica G; Bagaglio S; Cicconi P; Capobianchi MR; Pellizzer G; Caramello P; Orani A; Moioli C; Rizzardini G; Uberti-Foppa C; Puoti M; Monforte AD;
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):574-81. PubMed ID: 19590432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women.
    Crystal HA; Weedon J; Holman S; Manly J; Valcour V; Cohen M; Anastos K; Liu C; Mack WJ; Golub E; Lazar J; Ho A; Kreek MJ; Kaplan RC
    J Neurovirol; 2011 Oct; 17(5):469-76. PubMed ID: 22006469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand.
    Ngo-Giang-Huong N; Jourdain G; Sirirungsi W; Decker L; Khamduang W; Le Coeur S; Sirinontakan S; Somsamai R; Pagdi K; Hemvuttiphan J; McIntosh K; Barin F; Lallemant M
    Int J Infect Dis; 2010 Jul; 14(7):e602-7. PubMed ID: 20047847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus.
    Collazos J; Cartón JA; Asensi V
    Curr HIV Res; 2011 Jul; 9(5):339-45. PubMed ID: 21827383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive effects of HIV, hepatitis C, and substance use history.
    Devlin KN; Gongvatana A; Clark US; Chasman JD; Westbrook ML; Tashima KT; Navia B; Cohen RA
    J Int Neuropsychol Soc; 2012 Jan; 18(1):68-78. PubMed ID: 22132928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
    Nowicki MJ; Laskus T; Nikolopoulou G; Radkowski M; Wilkinson J; Du WB; Rakela J; Kovacs A
    J Infect Dis; 2005 Nov; 192(9):1557-65. PubMed ID: 16206070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
    Bambha K; Pierce C; Cox C; French AL; Tien PC; Sharp GB; Augenbraun M; Glesby MJ; Villacres MC; Plankey M; Strickler HD; Gange SJ; Peters MG
    AIDS; 2012 Mar; 26(5):599-607. PubMed ID: 22156972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women.
    Tien PC; Bacchetti P; Gripshover B; Overton ET; Rimland D; Kotler D;
    J Acquir Immune Defic Syndr; 2007 May; 45(1):60-5. PubMed ID: 17356466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
    Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
    BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C and progression of HIV disease.
    Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
    JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE; Hershow R; Kalish LA; Hardy WD; Zuckerman E; Levine A; Delapenha R; DeHovitz J; Greenblatt RM; Anastos K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):513-8. PubMed ID: 9859966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients.
    Ciccarelli N; Fabbiani M; Grima P; Falasca K; Tana M; Baldonero E; Colafigli M; Silveri MC; Vecchiet J; Cauda R; Di Giambenedetto S
    Infection; 2013 Dec; 41(6):1103-9. PubMed ID: 23839213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.
    French AL; Operskalski E; Peters M; Strickler HD; Tien PC; Sharp GB; Glesby MJ; Young M; Augenbraun M; Seaberg E; Kovacs A
    J Infect Dis; 2007 May; 195(10):1437-42. PubMed ID: 17436223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric impact of hepatitis C on advanced HIV.
    Ryan EL; Morgello S; Isaacs K; Naseer M; Gerits P;
    Neurology; 2004 Mar; 62(6):957-62. PubMed ID: 15037699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in hepatitis C viral response after initiation of highly active antiretroviral therapy and control of HIV viremia in chronically co-infected individuals.
    Kottilil S; Jagannatha S; Lu A; Liu S; McLaughlin M; Metcalf JA; Dewar R; Campbell C; Koratich C; Maldarelli F; Masur H; Polis MA
    HIV Clin Trials; 2004; 5(1):25-32. PubMed ID: 15002084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.
    de Larrañaga GF; Wingeyer SD; Puga LM; Alonso BS; Benetucci JA
    Eur J Clin Microbiol Infect Dis; 2006 Feb; 25(2):98-103. PubMed ID: 16477441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
    De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
    Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
    Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
    Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.